These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 35508105)
21. D-3-phosphoglycerate dehydrogenase from the silkworm Bombyx mori: Identification, functional characterization, and expression. Yamamoto K; Mohri S; Furuya S Arch Insect Biochem Physiol; 2021 Jan; 106(1):e21751. PubMed ID: 33058282 [TBL] [Abstract][Full Text] [Related]
22. Yap/Taz activity is associated with increased expression of phosphoglycerate dehydrogenase that supports myoblast proliferation. Meinhold M; Verbrugge S; Shi A; Schönfelder M; Becker L; Jaspers RT; Zammit PS; Wackerhage H Cell Tissue Res; 2024 Mar; 395(3):271-283. PubMed ID: 38183459 [TBL] [Abstract][Full Text] [Related]
23. Repression of phosphoglycerate dehydrogenase sensitizes triple-negative breast cancer to doxorubicin. Zhang X; Bai W Cancer Chemother Pharmacol; 2016 Sep; 78(3):655-9. PubMed ID: 27473325 [TBL] [Abstract][Full Text] [Related]
24. Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells. Sharif T; Martell E; Dai C; Ghassemi-Rad MS; Lee K; Singh SK; Weaver ICG; Gujar S Cell Death Dis; 2018 Sep; 9(10):990. PubMed ID: 30250195 [TBL] [Abstract][Full Text] [Related]
25. Downregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3. Jing Z; Heng W; Xia L; Ning W; Yafei Q; Yao Z; Shulan Z Cancer Biol Ther; 2015; 16(4):541-8. PubMed ID: 25719555 [TBL] [Abstract][Full Text] [Related]
26. Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth. Chen J; Chung F; Yang G; Pu M; Gao H; Jiang W; Yin H; Capka V; Kasibhatla S; Laffitte B; Jaeger S; Pagliarini R; Chen Y; Zhou W Oncotarget; 2013 Dec; 4(12):2502-11. PubMed ID: 24318446 [TBL] [Abstract][Full Text] [Related]
27. PHGDH: a novel therapeutic target in cancer. Lee CM; Hwang Y; Kim M; Park YC; Kim H; Fang S Exp Mol Med; 2024 Jul; 56(7):1513-1522. PubMed ID: 38945960 [TBL] [Abstract][Full Text] [Related]
28. eIF3i promotes colorectal cancer cell survival via augmenting PHGDH translation. Zhang Y; Wan X; Yang X; Liu X; Huang Q; Zhou L; Zhang S; Liu S; Xiong Q; Wei M; Qiu L; Zhang B; Han J J Biol Chem; 2023 Sep; 299(9):105177. PubMed ID: 37611825 [TBL] [Abstract][Full Text] [Related]
29. ASS1 inhibits triple-negative breast cancer by regulating PHGDH stability and de novo serine synthesis. Luo W; Zou Z; Nie Y; Luo J; Ming Z; Hu X; Luo T; Ouyang M; Liu M; Tang H; Xie Y; Peng K; Chen L; Zhou J; Luo Z Cell Death Dis; 2024 May; 15(5):319. PubMed ID: 38710705 [TBL] [Abstract][Full Text] [Related]
31. Non-canonical phosphoglycerate dehydrogenase activity promotes liver cancer growth via mitochondrial translation and respiratory metabolism. Shu Y; Hao Y; Feng J; Liu H; Li ST; Feng J; Jiang Z; Ye L; Zhou Y; Sun Y; Zhou Z; Wei H; Gao P; Zhang H; Sun L EMBO J; 2022 Dec; 41(23):e111550. PubMed ID: 36314841 [TBL] [Abstract][Full Text] [Related]
32. The NMDA receptor activation by d-serine and glycine is controlled by an astrocytic Phgdh-dependent serine shuttle. Neame S; Safory H; Radzishevsky I; Touitou A; Marchesani F; Marchetti M; Kellner S; Berlin S; Foltyn VN; Engelender S; Billard JM; Wolosker H Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20736-20742. PubMed ID: 31548413 [TBL] [Abstract][Full Text] [Related]
33. Selective upregulation of 3-phosphoglycerate dehydrogenase (Phgdh) expression in adult subventricular zone neurogenic niche. Kinoshita MO; Shinoda Y; Sakai K; Hashikawa T; Watanabe M; Machida T; Hirabayashi Y; Furuya S Neurosci Lett; 2009 Mar; 453(1):21-6. PubMed ID: 19429008 [TBL] [Abstract][Full Text] [Related]
34. Requirement of the expression of 3-phosphoglycerate dehydrogenase for traversing S phase in murine T lymphocytes following immobilized anti-CD3 activation. Jun do Y; Taub D; Chrest FJ; Kim YH Cell Immunol; 2014 Feb; 287(2):78-85. PubMed ID: 24434753 [TBL] [Abstract][Full Text] [Related]
35. Multi-omics Analysis of the Role of PHGDH in Colon Cancer. Dai Z; Chen L; Pan K; Zhao X; Xu W; Du J; Xing C Technol Cancer Res Treat; 2023; 22():15330338221145994. PubMed ID: 36707056 [No Abstract] [Full Text] [Related]
36. Deletion of PHGDH in adipocytes improves glucose intolerance in diet-induced obese mice. Okabe K; Usui I; Yaku K; Hirabayashi Y; Tobe K; Nakagawa T Biochem Biophys Res Commun; 2018 Sep; 504(1):309-314. PubMed ID: 30180949 [TBL] [Abstract][Full Text] [Related]
37. Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression. Barnabas GD; Lee JS; Shami T; Harel M; Beck L; Selitrennik M; Jerby-Arnon L; Erez N; Ruppin E; Geiger T Cancer Res; 2021 Mar; 81(6):1443-1456. PubMed ID: 33500247 [TBL] [Abstract][Full Text] [Related]
38. Elevated Nuclear PHGDH Synergistically Functions with cMyc to Reshape the Immune Microenvironment of Liver Cancer. Zhu H; Yu H; Zhou H; Zhu W; Wang X Adv Sci (Weinh); 2023 Jun; 10(17):e2205818. PubMed ID: 37078828 [TBL] [Abstract][Full Text] [Related]
39. Drug Resistant Melanoma May Be Vulnerable to Inhibitors of Serine Synthesis. Doepner M; Lee IY; Ridky TW J Invest Dermatol; 2020 Nov; 140(11):2114-2116. PubMed ID: 33099398 [TBL] [Abstract][Full Text] [Related]
40. PHGDH Inhibits Ferroptosis and Promotes Malignant Progression by Upregulating SLC7A11 in Bladder Cancer. Shen L; Zhang J; Zheng Z; Yang F; Liu S; Wu Y; Chen Y; Xu T; Mao S; Yan Y; Li W; Zhang W; Yao X Int J Biol Sci; 2022; 18(14):5459-5474. PubMed ID: 36147463 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]